Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single‐institute experience in Japan
- 7 December 2007
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 80 (3) , 251-257
Abstract
Cytomegalovirus (CMV) disease is one of the major infectious complications after allogeneic hematopoietic stem cell transplantation (SCT). Several studies have shown that CMV‐seropositive patients have a substantial survival disadvantage after bone marrow transplantation (BMT) or peripheral blood SCT (PBSCT). Between August 1998 and February 2006, 101 adult patients underwent myeloablative cord blood transplantation (CBT) from unrelated donors at our institution. Sixteen and 85 patients were CMV‐seronegative and CMV‐seropositive, respectively, prior to CBT. Outcomes of CBT were compared between CMV‐seronegative and CMV‐seropositive patients. The cumulative incidences of neutrophil engraftment at 60 d after CBT did not differ between CMV‐seronegative and CMV‐seropositive patients (100% and 94%, P = 0.09); however, the cumulative incidence of platelet engraftment at 100 d was higher in CMV‐seronegative patients than CMV‐seropositive patients (100% vs. 86%, P < 0.005). The cumulative incidence of CMV antigenemia at 100 d was lower in CMV‐seronegative patients than CMV‐seropositive patients (0% vs. 77%, P < 0.001); however, the cumulative incidences of CMV disease did not differ between CMV‐seronegative and CMV‐seropositive patients (0% vs. 1%, P = 0.84). The probabilities of disease‐free survival at 2 yr also did not differ between CMV‐seronegative and CMV‐seropositive patients (92% vs. 72%, P = 0.16). The outcomes of CBT for CMV‐seropositive patients as well as CMV‐seronegative patients in our series were favorable. This might be due to effective antiviral therapy for CMV infection. Large‐scale studies are needed to determine the impact of recipient CMV serostatus on the outcome of CBT for adults.Keywords
This publication has 16 references indexed in Scilit:
- Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignanciesBlood, 2004
- Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute LeukemiaNew England Journal of Medicine, 2004
- Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with LeukemiaNew England Journal of Medicine, 2004
- The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapyBlood, 2004
- Definitions of Cytomegalovirus Infection and Disease in Transplant RecipientsClinical Infectious Diseases, 2002
- High Risk of Death Due to Bacterial and Fungal Infection among Cytomegalovirus (CMV)–Seronegative Recipients of Stem Cell Transplants from Seropositive Donors: Evidence for Indirect Effects of Primary CMV InfectionThe Journal of Infectious Diseases, 2002
- Estimation of failure probabilities in the presence of competing risks: new representations of old estimatorsStatistics in Medicine, 1999
- Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes.Proceedings of the National Academy of Sciences, 1992
- Chronic graft-versus-host syndrome in manThe American Journal of Medicine, 1980
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974